Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

09 Oct, 2017, 09:05 BST The Hard Truth About Eczema: It's Something in the Water

Hard water damages our protective skin barrier and could contribute to the development of skin conditions, a new study has shown from the...


09 Oct, 2017, 07:00 BST First Patient Treated With Microscopic Beads Pre-loaded With a Targeted Cancer Drug and Visible on CT Scans

Researchers from the UCL Cancer Institute and the specialist healthcare company BTG plc (LSE: BTG) have begun the first clinical trial of an...


06 Oct, 2017, 10:16 BST Cantargia Obtains Patent Approval in USA for the Antibody CAN04 in Development for Treatment of Cancer

Cantargia AB ("Cantargia") today announces that the United States Patent and Trademark Office ("USPTO") has granted the company's patent...


04 Oct, 2017, 09:00 BST Sequana Medical Announces Publication of Results of alfapump® Multicentre, Post-Marketing Surveillance Registry in Alimentary Pharmacology & Therapeutics (AP&T)

Sequana Medical AG (Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, announces the...


03 Oct, 2017, 13:49 BST Arbor Pharmaceuticals, LLC and Debiopharm International SA Announce Commercial Availability of Triptodur™, Triptorelin 6-month Formulation, for Treatment of Central Precocious Puberty (CPP)

Triptodur™, (triptorelin) extended release injectable suspension, has been shown to arrest or reverse the clinical signs of puberty associated...


03 Oct, 2017, 12:00 BST Vantia Therapeutics Announces Positive Results From its Phase III EQUINOC Study, a Pivotal Trial with Fedovapagon for the Treatment of Nocturia in Men with Benign Prostatic Hyperplasia

Vantia Therapeutics announces positive top-line data from a pivotal Phase III trial investigating the efficacy and safety of fedovapagon...


03 Oct, 2017, 07:00 BST Audentes Therapeutics Announces MHRA Approval of Clinical Trial Authorisation Application for AT132 to Treat X-Linked Myotubular Myopathy

Preliminary data from ASPIRO, the ongoing Phase 1/2 Clinical Study of AT132, expected in fourth quarter of 2017 Audentes Therapeutics, Inc....


02 Oct, 2017, 13:03 BST CartiHeal Performs the First 16 Cases in the Agili-C™ Implant IDE Multinational Pivotal Study

CartiHeal, developer of Agili-C, proprietary implants for the treatment of joint surface lesions, announced today the initiation of Its IDE...


02 Oct, 2017, 12:35 BST SELLAS Enters into a Clinical Trial Collaboration and Supply Agreement with Merck & Co., Inc., Kenilworth, N.J., USA

Initiation of a Phase 1/2 Combination Clinical Trial with Galinpepimut-S and KEYTRUDA® (pembrolizumab) Across Various Indications Expected in 1H,...


02 Oct, 2017, 06:00 BST Pharming Announces Positive Data From Paediatric Clinical Trial With RUCONEST®

RUCONEST® provided clinically meaningful relief of symptoms in children with hereditary angioedema Pharming Group N.V. ("Pharming" or "the...


29 Sep, 2017, 19:24 BST Pharming Announces Positive Data from Paediatric Clinical Trial with RUCONEST®

RUCONEST® provided clinically meaningful relief of symptoms in children with hereditary angioedema Pharming Group N.V. ("Pharming" or "the...


29 Sep, 2017, 09:27 BST Camurus Announces European Medicines Agency Validation of CAM2038 Marketing Authorization Application for Treatment of Opioid Dependence

Camurus (NASDAQ STO: CAMX) today announced the company's Marketing Authorization Application (MAA) for the investigational, weekly and monthly...


28 Sep, 2017, 14:00 BST Turacoz Healthcare Solutions Picks Acceliant to Strengthen Clinical Trial Offerings

Acceliant, the global leader in e-clinical data management solutions, has partnered with Turacoz, a leading medical communications company that...


27 Sep, 2017, 09:00 BST KaNDy Therapeutics Launched to Advance a Breakthrough Treatment in Women's Health

First-in-class once daily NT-814 spun out of NeRRe Therapeutics into new company KaNDy Therapeutics has been launched today to maximise the...


27 Sep, 2017, 08:00 BST SI-BONE, Inc. Announces Publication of iMIA - a 2nd Multicenter Randomized Controlled Trial of the iFuse Implant System® vs Conservative Care

One-Year Results for more than 100 patients at 9 Hospitals in 4 European Countries Show that the iFuse Implant™ is Safe and More Effective than...


26 Sep, 2017, 12:30 BST 10-year Data Shows CyberKnife® System Provides Excellent Long-term Control of Low-Risk Prostate Cancer

First Study to Evaluate the Use of Stereotactic Body Radiation Therapy in Low-Risk Prostate Cancer 10 Years Post Treatment Accuray Incorporated...


26 Sep, 2017, 12:01 BST Medicago Announces Phase 3 Study of VLP Quadrivalent Influenza Vaccine

The first plant-based seasonal flu vaccine candidate reaches final clinical stage Medicago, a Canadian biopharmaceutical company and leader in...


25 Sep, 2017, 13:57 BST New NephroCheck® Test Outcomes Data Show Significant Reduction in Kidney Injury, Hospital Stay

RANDOMIZED CONTROL TRIAL REPORTS 66 PERCENT REDUCTION IN MODERATE TO SEVERE ACUTE KIDNEY INJURY; 5-DAY REDUCTION IN TOTAL HOSPITAL STAY Ortho...


25 Sep, 2017, 11:19 BST eTheRNA immunotherapies Awarded €1 Million Grant From Flanders Innovation & Entrepreneurship to Further Upgrade its State-of-the-art Production Process for TriMix mRNA Immunotherapies

eTheRNA immunotherapies, a clinical-stage company developing mRNA-based cancer immunotherapies from its unique TriMix platform, announces it has...


25 Sep, 2017, 07:00 BST Norgine Launches New Discussion Paper - Scope for Change: What Next for European Colonoscopy Services?

Norgine B.V. today announced it has launched a new discussion paper "Scope for change: what next for European colonoscopy services?" which...


22 Sep, 2017, 08:20 BST Natera Selected for Circulating Tumor DNA Study in Bladder Cancer

Denmark's Aarhus University to Use Signatera™ ctDNA Technology in Longitudinal Study Natera, Inc., (NASDAQ: NTRA), a global leader in...


21 Sep, 2017, 07:59 BST Alligator Bioscience to Present ADC-1013 Intratumoral Clinical Phase I Study Results at SITC in November 2017

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy,...


20 Sep, 2017, 18:00 BST deCODE Study Reveals an Ancient Achilles Heel in the Human Genome

- The generation of new mutations is a key driver of evolution but also of susceptibility to rare diseases - Fathers pass on...


20 Sep, 2017, 13:00 BST Norgine Launches LYMPHOSEEK®▼ (99mTc-tilmanocept) in Italy

Norgine B.V. today announced the launch of LYMPHOSEEK® (technetium Tc 99m tilmanocept) in Italy. LYMPHOSEEK® is a radiopharmaceutical used for...


20 Sep, 2017, 11:49 BST Edinburgh Molecular Imaging Commences Phase II European Cancer Trial

Edinburgh Molecular Imaging (EM Imaging), the clinical phase biotechnology company focused on enabling image-guided therapy, announces it has...